KIT and neoplasm: MiR-200b-3p was demonstrated to directly target EGFR and indirectly affected ETV1 protein levels, whereas miR-375-3p targeted KIT. A cell line study by Lu et al. revealed that miR-152 is downregulated in GIST cells, and its overexpression inhibited tumor cell proliferation and induced apoptosis [99].